Advertisement

Browse Subject Areas

?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

Chronic myeloid leukemia

Machine learning driven dashboard for chronic myeloid leukemia prediction using protein sequences

Waqar Ahmad, Abdul Raheem Shahzad, Muhammad Awais Amin, Waqas Haider Bangyal, Tahani Jaser Alahmadi, Saddam Hussain Khan

published 18 Jun 2025

Loading metrics information...

Metrics unavailable. Please check back later.

Enabling access to molecular monitoring for chronic myeloid leukemia patients is cost effective in China

Vikalp Kumar Maheshwari, Cassandra Slader, Nidhi Dani, Christina Gkitzia, Quan Yuan, Tengbin Xiong, Yu Liu, Ricardo Viana

published 25 Oct 2021

Loading metrics information...

Metrics unavailable. Please check back later.

Diagnostic performance of the molecular BCR-ABL1 monitoring system may impact on inclusion of CML patients in stopping trials

Birgit Spiess, Sébastien Rinaldetti, Nicole Naumann, Norbert Galuschek, Ute Kossak-Roth, Patrick Wuchter, Irina Tarnopolscaia, Diana Rose, Astghik Voskanyan, Alice Fabarius, Wolf-Karsten Hofmann, Susanne Saußele, Wolfgang Seifarth

published 21 Mar 2019

Loading metrics information...

Metrics unavailable. Please check back later.

Prevalence and determinants of non-adherence to Imatinib in the first 3-months treatment among newly diagnosed Ethiopian’s with chronic myeloid leukemia

Atalay Mulu Fentie, Fishatsion Tadesse, Ephrem Engidawork, Am Gebremedhin

published 07 Mar 2019

Loading metrics information...

Metrics unavailable. Please check back later.

A new highly sensitive real-time quantitative-PCR method for detection of BCR-ABL1 to monitor minimal residual disease in chronic myeloid leukemia after discontinuation of imatinib

Hiroaki Kitamura, Yoko Tabe, Tomohiko Ai, Koji Tsuchiya, Maiko Yuri, Shigeki Misawa, Takashi Horii, Atsushi Kawaguchi, Akimichi Ohsaka, Shinya Kimura

published 05 Mar 2019

Loading metrics information...

Metrics unavailable. Please check back later.

The benefit of quality control charts (QCC) for routine quantitative BCR-ABL1 monitoring in chronic myeloid leukemia

Birgit Spiess, Nicole Naumann, Norbert Galuschek, Sébastien Rinaldetti, Ute Kossak-Roth, Irina Tarnopolscaia, Elena Felde, Alice Fabarius, Wolf-Karsten Hofmann, Susanne Saußele, Wolfgang Seifarth

published 24 Apr 2018

Loading metrics information...

Metrics unavailable. Please check back later.

Copy number variation analysis in cytochromes and glutathione S-transferases may predict efficacy of tyrosine kinase inhibitors in chronic myeloid leukemia

Alexander V. Lavrov, Oksana A. Ustaeva, Elmira P. Adilgereeva, Svetlana A. Smirnikhina, Ekaterina Y. Chelysheva, Oleg A. Shukhov, Yuriy V. Shatokhin, Sergey V. Mordanov, Anna G. Turkina, Sergey I. Kutsev

published 13 Sep 2017

Loading metrics information...

Metrics unavailable. Please check back later.

A BCR-ABL1 cutoff of 1.5% at 3 months, determined by the GeneXpert system, predicts an optimal response in patients with chronic myeloid leukemia

Valentín García-Gutiérrez, María T. Gómez-Casares, José M. Puerta, Juan M. Alonso-Domínguez, Santiago Osorio, Juan C. Hernández-Boluda, Rosa Collado, María J. Ramírez, Fátima Ibáñez, María L. Martín, Juan D. Rodríguez-Gambarte, Carolina Martínez-Laperche, Montse Gómez, Dolly V. Fiallo, Sara Redondo, Alicia Rodríguez, Concepción Ruiz-Nuño, Juan L. Steegmann, Antonio Jiménez-Velasco, Spanish Group of Chronic Myeloid Leukemia (GELMC)

published 09 Mar 2017

Loading metrics information...

Metrics unavailable. Please check back later.

BEST: Next-Generation Biomedical Entity Search Tool for Knowledge Discovery from Biomedical Literature

Sunwon Lee, Donghyeon Kim, Kyubum Lee, Jaehoon Choi, Seongsoon Kim, Minji Jeon, Sangrak Lim, Donghee Choi, Sunkyu Kim, Aik-Choon Tan, Jaewoo Kang

published 19 Oct 2016

Loading metrics information...

Metrics unavailable. Please check back later.

BCR-ABL Promotes PTEN Downregulation in Chronic Myeloid Leukemia

Cristina Panuzzo, Sabrina Crivellaro, Giovanna Carrà, Angelo Guerrasio, Giuseppe Saglio, Alessandro Morotti

published 24 Oct 2014

Loading metrics information...

Metrics unavailable. Please check back later.

Major Molecular Response Achievement in CML Patients Can Be Predicted by BCR-ABL1/ABL1 or BCR-ABL1/GUS Ratio at an Earlier Time Point of Follow-Up than Currently Recommended

Sarah Huet, Pascale Cony-Makhoul, Maël Heiblig, Isabelle Tigaud, Sophie Gazzo, Amine Belhabri, Denis Souche, Mauricette Michallet, Jean-Pierre Magaud, Sandrine Hayette, Franck Nicolini

published 09 Sep 2014

Loading metrics information...

Metrics unavailable. Please check back later.

Growth Arrest Specific 2 Is Up-Regulated in Chronic Myeloid Leukemia Cells and Required for Their Growth

Haixia Zhou, Yue Ge, Lili Sun, Wenjuan Ma, Jie Wu, Xiuyan Zhang, Xiaohui Hu, Connie J. Eaves, Depei Wu, Yun Zhao

published 21 Jan 2014

Loading metrics information...

Metrics unavailable. Please check back later.

Increased Level of Myeloid-Derived Suppressor Cells, Programmed Death Receptor Ligand 1/Programmed Death Receptor 1, and Soluble CD25 in Sokal High Risk Chronic Myeloid Leukemia

Lisa Christiansson, Stina Söderlund, Emma Svensson, Satu Mustjoki, Mats Bengtsson, Bengt Simonsson, Ulla Olsson-Strömberg, Angelica S. I. Loskog

published 31 Jan 2013

Loading metrics information...

Metrics unavailable. Please check back later.

Advertisement

Create a weekly email alert for: Chronic myeloid leukemia

You can change these options by clicking profile then "Alerts and Notifications"